Basic fibroblast growth factor (FGF2) is a potent wide-spectrum mitogen whose overexpression is associated with immortalization and unregulated cell proliferation in many tumors. The FGF2 gene locus is bi-directionally transcribed to produce FGF2 mRNA from the “sense” strand and a cis-antisense RNA (NUDT6) from the NUDT6 gene on the “antisense” strand. The NUDT6 gene encodes a nudix motif protein of unknown function, while its mRNA has been implicated in the post-transcriptional regulation of FGF2 expression. FGF2 and NUDT6 are co-expressed in rat C6 glioma cells, and ectopic overexpression of NUDT6 suppresses cellular FGF2 accumulation and cell cycle progression. However, the role of the endogenous antisense RNA in regulation of FGF2 is unclear. In the present study, we employed siRNA-mediated gene knockdown to examine the role of the endogenous NUDT6 RNA in regulation of FGF2 expression and cell cycle progression. Knockdown of either FGF2 or NUDT6 mRNA was accompanied by a significant (>3 fold) increase in the complementary partner RNA. Similar reciprocal effects were observed at the protein level, indicating that these two transcripts are mutually regulatory. Remarkably, knockdown of either FGF2 or NUDT6 significantly reduced cell proliferation and inhibited S-phase re-entry following serum deprivation, implicating both FGF2 and NUDT6 in the regulation of cell transformation and cell cycle progression.
References
[1]
Yelin, R.; Dahary, D.; Sorek, R.; Levanon, E.Y.; Goldstein, O.; Shoshan, A.; Diber, A.; Biton, S.; Tamir, Y.; Khosravi, R.; et al. Widespread occurrence of antisense transcription in the human genome. Nat. Biotechnol. 2003, 21, 379–386, doi:10.1038/nbt808.
[2]
Morris, K.V. Long antisense non-coding rnas function to direct epigenetic complexes that regulate transcription in human cells. Epigenetics 2009, 4, 296–301, doi:10.4161/epi.4.5.9282.
[3]
Svoboda, P. Long dsrna and silent genes strike back:Rnai in mouse oocytes and early embryos. Cytogenet. Genome Res. 2004, 105, 422–434, doi:10.1159/000078215.
[4]
McLennan, A.G. The nudix hydrolase superfamily. Cell. Mol. Life Sci. 2006, 63, 123–143, doi:10.1007/s00018-005-5386-7.
Sukhthankar, M.; Choi, C.K.; English, A.; Kim, J.S.; Baek, S.J. A potential proliferative gene, nudt6, is down-regulated by green tea catechins at the posttranscriptional level. J. Nutr. Biochem. 2009.
[8]
Gagnon, M.L.; Moy, G.K.; Klagsbrun, M. Characterization of the promoter for the human antisense fibroblast growth factor-2 gene; regulation by ets in jurkat t cells. J. Cell. Biochem. 1999, 72, 492–506, doi:10.1002/(SICI)1097-4644(19990315)72:4<492::AID-JCB5>3.0.CO;2-H.
[9]
Knee, R.; Li, A.W.; Murphy, P.R. Characterization and tissue-specific expression of the rat basic fibroblast growth factor antisense mrna and protein. Proc. Natl. Acad. Sci. USA 1997, 94, 4943–4947.
[10]
Kimelman, D.; Kirschner, M.W. An antisense messenger rna directs the covalent modification of the transcript encoding fibroblast growth factor in xenopus oocytes. Cell 1989, 59, 687–696, doi:10.1016/0092-8674(89)90015-9.
[11]
Zuniga Mejia Borja, A.; Meijers, C.; Zeller, L. Expression of alternatively spliced bfgf first coding exons and antisense mrnas during chicken embryogenesis. Dev. Biol. 1993, 157, 110–118, doi:10.1006/dbio.1993.1116.
[12]
Knee, R.S.; Pitcher, S.E.; Murphy, P.R. Basic fibroblast growth factor sense (fgf) and antisense (gfg) rna transcripts are expressed in unfertilized human oocytes and in differentiated adult tissues. Biochem. Biophys. Res. Comm. 1994, 205, 577–583, doi:10.1006/bbrc.1994.2704.
[13]
Li, A.; Seyoum, G.; Shiu, R.; Murphy, P. Expression of the rat bfgf antisense rna transcript is tissue-specific and developmentally regulated. Mol. Cell. Endocrinol. 1996, 118, 113–123, doi:10.1016/0303-7207(96)03772-0.
[14]
Baguma-Nibasheka, M.; Li, A.W.; Osman, M.S.; Geldenhuys, L.; Casson, A.G.; Too, C.K.; Murphy, P.R. Coexpression and regulation of the fgf-2 and fgf antisense genes in leukemic cells. Leuk. Res. 2005, 29, 423–433, doi:10.1016/j.leukres.2004.09.006.
[15]
Barclay, C.; Li, A.W.; Geldenhuys, L.; Baguma-Nibasheka, M.; Porter, G.A.; Veugelers, P.J.; Murphy, P.R.; Casson, A.G. Basic fibroblast growth factor (fgf-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the fgf-2 antisense gene. Clin. Cancer Res. 2005, 11, 7683–7691, doi:10.1158/1078-0432.CCR-05-0771.
[16]
Zhang, S.C.; Barclay, C.; Alexander, L.A.; Geldenhuys, L.; Porter, G.A.; Casson, A.G.; Murphy, P.R. Alternative splicing of the fgf antisense gene: Differential subcellular localization in human tissues and esophageal adenocarcinoma. J. Mol. Med. (Berlin, Germany) 2007, 85, 1215–1228, doi:10.1007/s00109-007-0219-9.
[17]
MacFarlane, L.A.; Murphy, P.R. Regulation of fgf-2 by an endogenous antisense rna: Effects on cell adhesion and cell-cycle progression. Mol. Carcinog. 2010, 49, 1031–1044, doi:10.1002/mc.20686.
[18]
Mihalich, A.; Reina, M.; Mangioni, S.; Ponti, E.; Alberti, L.; Vigano, P.; Vignali, M.; di Blasio, A.M. Different basic fibroblast growth factor and fibroblast growth factor-antisense expression in eutopic endometrial stromal cells derived from women with and without endometriosis. J. Clin. Endocrinol. Metab. 2003, 88, 2853–2859, doi:10.1210/jc.2002-021434.
[19]
Baguma-Nibasheka, M.; Li, A.W.; Murphy, P.R. The fibroblast growth factor-2 antisense gene inhibits nuclear accumulation of fgf-2 and delays cell cycle progression in c6 glioma cells. Mol. Cell. Endocrinol. 2007, 267, 127–136, doi:10.1016/j.mce.2007.01.008.
[20]
Li, A.W.; Murphy, P.R. Expression of alternatively spliced fgf-2 antisense rna transcripts in the central nervous system: Regulation of fgf-2 mrna translation. Mol. Cell. Endocrinol. 2000, 170, 233–242.
[21]
Arese, M.; Chen, Y.; Florkiewicz, R.Z.; Gualandris, A.; Shen, B.; Rifkin, D.B. Nuclear activities of basic fibroblast growth factor: Potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals. Mol. Biol. Cell 1999, 10, 1429–1444.
[22]
Arnaud, E.; Touriol, C.; Boutonnet, C.; Gensac, M.-C.; Vagner, S.; Prats, H.; Prats, A.-C. A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-aug start codon and behaves as a survival factor. Mol. Cell. Biol. 1999, 19, 505–514.
[23]
Vagner, S.; Gensac, M.C.; Maret, A.; Bayard, F.; Amalric, F.; Prats, H.; Prats, A.C. Alternative translation of human fibroblast growth factor 2 mrna occurs by internal entry of ribosomes. Mol. Cell. Biol. 1995, 15, 35–44.
[24]
Mignatti, P.; Morimoto, T.; Rifkin, D.B. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-golgi complex. J. Cell Physiol. 1992, 151, 81–93, doi:10.1002/jcp.1041510113.
[25]
Murphy, P.R.; Knee, R.S. Basic fibroblast growth factor binding and processing by human glioma cells. Mol. Cell. Endocrinol. 1995, 114, 193–203, doi:10.1016/0303-7207(95)96800-W.
[26]
Amalric, F.; Bouche, G.; Bonnet, H.; Brethenou, P.; Roman, A.M.; Truchet, I.; Quarto, N. Fibroblast growth factor-2 (fgf-2) in the nucleus: Translocation process and targets. Biochem. Pharmacol. 1994, 47, 111–115.
[27]
Delrieu, I. The high molecular weight isoforms of basic fibroblast growth factor (fgf-2): An insight into an intracrine mechanism. FEBS Lett. 2000, 468, 6–10, doi:10.1016/S0014-5793(00)01189-3.
[28]
Zhang, S.C.; MacDonald, K.A.; Baguma-Nibasheka, M.; Geldenhuys, L.; Casson, A.G.; Murphy, P.R. Alternative splicing and differential subcellular localization of the rat fgf antisense gene product. BMC Mol. Biol. 2008, 9.
[29]
Murphy, P.; Sato, Y.; Knee, R. Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line. Mol. Endocrinol. 1992, 6, 877–884, doi:10.1210/me.6.6.877.
[30]
Katayama, S.; Tomaru, Y.; Kasukawa, T.; Waki, K.; Nakanishi, M.; Nakamura, M.; Nishida, H.; Yap, C.C.; Suzuki, M.; Kawai, J.; et al. Antisense transcription in the mammalian transcriptome. Science (New York, N.Y.) 2005, 309, 1564–1566.
[31]
Wahlestedt, C. Natural antisense and noncoding rna transcripts as potential drug targets. Drug Discov. Today 2006, 11, 503–508, doi:10.1016/j.drudis.2006.04.013.
